Bluebird Bio (BLUE) Could Cure Sickle Cell Anemia: Piper Jaffray

Bluebird bio Inc (NASDAQ:BLUE) stock surged 6% Friday, after Piper Jaffray analyst Joshua Schimmer included "bluebird bio curing sickle cell anemia" in his list of top 15 potential "Surprise" Biopharma Events in 2015.